DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Gianni L, Mansutti M, Anton A. et al.
Comparing Neoadjuvant Nab-paclitaxel vs. Paclitaxel Both Followed by Anthracycline Regimens in Women With ERBB2/HER2-Negative Breast Cancer-The Evaluating Treatment With Neoadjuvant Abraxane (ETNA) Trial: A Randomized Phase 3 Clinical Trial.
JAMA Oncol 2018;
4: 302-308
We do not assume any responsibility for the contents of the web pages of other providers.